HIV Vaccine Development Threatened by US Policy Changes

HIV continues to infect and kill people disproportionately in sub-Saharan Africa.

Early last year, a hundred researchers, clinicians and other experts on HIV discussed the development of an innovative vaccine that could prevent the disease.

But just as the meeting was about to wrap up, the mood darkened.

A new executive order signed by President Trump on the day of his inauguration, Jan. 20, 2025, had frozen all foreign aid pending a review.

Soon, DOGE would begin its decimation of USAID — and with it, this vaccine trial.

That is – until the South African researchers came up with a new plan.